The aim of the study was to observe the activation of DMN in patients with different types and location brain tumors, and as so to investigate whether the type and location of tumor would affect DMN spatial distribution. In our study, we compared the spatial distribution of DMN both glioma and meningioma. Finally, our findings show that DMN integrity is impaired as a result of tumor, and the DMN spatial distribution could be affected by the location of the brain tumor.
This abstract and the presentation materials are available to members only; a login is required.